Literature DB >> 8710747

Theoretical considerations on two equations for estimating the extent of absorption after oral administration of drugs.

Y Kwon1, P B Inskeep.   

Abstract

PURPOSE: The amount of drug absorbed into portal blood after oral dosing (Dp.o,g) has been estimated using Fick's principle (Q-method), i.e., Dp.o,g = Qh x (AUCp.o,g--AUCp.o,c), where Qh is the portal blood flow rate, and AUCp.o,g and AUCp.o,c are the areas under the concentration-time curves of portal vein and systemic blood after oral dosing, respectively. However, this method may underestimate Dp.o,g, when the drug is subject to systemic intestinal elimination. An alternate equation (CL-method; Dp.o,g = CLs x AUCp.o,g) is described using a simple pharmacokinetic model, to estimate Dp.o,g in the presence of systemic intestinal elimination, where CLs is systemic clearance.
METHODS: The model is composed of central, intestine and liver compartments, assuming that drug is eliminated by intestinal and/or hepatic pathways only. A comparison of both methods for estimating Dp.o,g was made using computer-simulation or experimental data of phenacetin from the literature.
RESULTS: The simulation study demonstrated that the Q-method underestimated Dp.o,g in the presence of significant intrinsic intestinal clearance, compared to the CL-method. The similar results were observed using the experimental data of phenacetin.
CONCLUSIONS: The CL-method can provide a better estimate of Dp.o,g, while the Q-method may underestimate Dp.o,g, when there is significant systemic intestinal elimination of drugs after oral administration. In addition, useful information for understanding the relationship between the extent of absorption and the first-pass effect by intestine and/or liver after oral dosing of drugs can be obtained from the present approach.

Entities:  

Mesh:

Year:  1996        PMID: 8710747     DOI: 10.1023/a:1016046004945

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Pharmacokinetic model of presystemic metabolism.

Authors:  W A Colburn; M Gibaldi
Journal:  Drug Metab Dispos       Date:  1978 Mar-Apr       Impact factor: 3.922

2.  Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat.

Authors:  R M Welch; C R Hughes; R L Deangelis
Journal:  Drug Metab Dispos       Date:  1976 Jul-Aug       Impact factor: 3.922

Review 3.  Presystemic drug elimination.

Authors:  P A Routledge; D G Shand
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

4.  Isoprenaline conjugation--a "true first-pass effect" in the dog intestine.

Authors:  K F Ilett; C T Dollery; D S Davies
Journal:  J Pharm Pharmacol       Date:  1980-05       Impact factor: 3.765

5.  The influence of diffusional barriers on presystemic gut elimination.

Authors:  P R Gwilt; S Comer; P R Chaturvedi; D H Waters
Journal:  Drug Metab Dispos       Date:  1988 Jul-Aug       Impact factor: 3.922

Review 6.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

7.  Presystemic elimination of drugs: theoretical considerations for quantifying the relative contribution of gut and liver.

Authors:  R F Minchin; K F Ilett
Journal:  J Pharm Sci       Date:  1982-04       Impact factor: 3.534

8.  Mechanism by which hydralazine increases propranolol bioavailability.

Authors:  D W Schneck; J E Vary
Journal:  Clin Pharmacol Ther       Date:  1984-04       Impact factor: 6.875

Review 9.  Kinetics and metabolism of paracetamol and phenacetin.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Method to estimate the rate and extent of intestinal absorption in conscious rats using an absorption probe and portal blood sampling.

Authors:  D J Hoffman; T Seifert; A Borre; H N Nellans
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.